HIV

ViiV Healthcare receives European Commission approval for Apretude
Pharmaceutical Business Review
Wed, 09/20/23 - 08:33 am
ViiV Healthcare
Europe
Apretude
HIV
AIDS
PrEP
FDA grants tentative approval for Viatris’ pediatric HIV drug
Business Today
Tue, 09/5/23 - 08:53 pm
Viatris
FDA
HIV
pediatrics
abacavir
dolutegravir/lamivudine
Absci and Caltech receive grant from Bill and Melinda Gates Foundation for HIV vaccine effort
Biopharma Reporter
Thu, 08/17/23 - 10:06 am
Absci
Caltech
grants
HIV
artificial intelligence
Gates Foundation
vaccines
HIV cell therapy startup Addimmune heads to Wall Street via blank-check merger
BioPharma Dive
Fri, 08/11/23 - 09:58 am
Addimmune
HIV
SPAC
Gilead unveils $6 million HIV and viral hepatitis initiative for Australian and Canadian indigenous communities
Biopharma Reporter
Fri, 07/28/23 - 10:27 am
Gilead Sciences
HIV
Australia
Canada
indigenous communities
J&J, GSK's ViiV tout switching study showing patients prefer their long-acting HIV med Cabenuva over Gilead rival
Fierce Pharma
Tue, 07/25/23 - 09:20 pm
JNJ
GSK
ViiV
Gilead Sciences
HIV
Cabenuva
Biktarvy
Statins reduce cardiovascular risk in people living with HIV, new global study finds
Stat
Mon, 07/24/23 - 09:58 am
statins
HIV
cardiovascular disease
Janssen’s newly-merged infectious disease and vaccine unit sees significant pipeline cuts
Fierce Biotech
Thu, 07/20/23 - 10:18 am
JNJ
Janssen
infectious disease
vaccines
hepatitis
HIV
Medicare proposes coverage for PrEP without patient cost sharing
Fierce Healthcare
Fri, 07/14/23 - 09:58 am
Medicare
CMS
HIV
PrEP
GSK's ViiV explores novel pathway to bring long-acting HIV med Cabenuva to tough-to-treat patients
Fierce Pharma
Thu, 07/6/23 - 10:07 pm
GSK
ViiV Healthcare
HIV
Cabenuva
Gilead, Teva prevail in high-stakes trial over HIV drug pay-for-delay claims
Fierce Pharma
Wed, 07/5/23 - 07:17 pm
Gilead Sciences
Teva Pharmaceutical
HIV
pay-for-delay
generics
legal
US appeal in high-stakes Gilead patent case garners support from patient advocates
Fierce Pharma
Thu, 06/1/23 - 11:27 am
Gilead Sciences
HIV
patents
legal
DOJ
Truvada
Gilead, Teva reach 11th-hour settlements with some groups in HIV antitrust case
Fierce Pharma
Mon, 05/29/23 - 12:26 pm
Gilead Sciences
Teva Pharmaceutical
HIV
legal
antitrust
After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California
Fierce Pharma
Thu, 05/25/23 - 01:10 pm
Gilead Sciences
Teva Pharmaceutical
legal
HIV
antitrust
Gilead notches trial win in high-stakes HIV patent case against US government
Fierce Pharma
Tue, 05/9/23 - 11:32 pm
Gilead Sciences
Truvada
HIV
Descovy
legal
patents
Vir Biotechnology awarded $10 million grant by Bill & Melinda Gates Foundation to develop HIV vaccine
Biopharma Reporter
Tue, 05/9/23 - 11:38 am
Vir Biotechnology
Gates Foundation
vaccines
HIV
Gilead gets big $175m judgment in HIV fraud case
Pharmaphorum
Fri, 03/10/23 - 09:55 am
Gilead Sciences
HIV
fraud
legal
reimbursement
CROI 2023 – GSK and Gilead’s long-acting HIV battle intensifies
EP Vantage
Mon, 02/27/23 - 07:01 pm
GSK
Gilead Sciences
CROI
Cabenuva
HIV
GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill
Yahoo/Reuters
Fri, 02/24/23 - 09:08 am
GSK
HIV
ViiV Healthcare
Gilead Sciences
Cabenuva
Biktarvy
Gilead Sciences reports positive data from HIV therapy trial
Clinical Trials Arena
Thu, 02/23/23 - 10:12 am
Gilead Sciences
lenacapavir
HIV
clinical trials

Pages